The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enanton (Leucorin Acetate) Market Research Report 2024
Synopsis
Leuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer's disease.
The global Enanton (Leucorin Acetate) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Enanton (Leucorin Acetate) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enanton (Leucorin Acetate) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enanton (Leucorin Acetate) include Sanofi, TOLMAR, Teva, Sandoz (Novartis), SciAnda Pharma, Daewoong, Nanox, GP Pharm and Enteris BioPharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enanton (Leucorin Acetate), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enanton (Leucorin Acetate).
Report Scope
The Enanton (Leucorin Acetate) market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enanton (Leucorin Acetate) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enanton (Leucorin Acetate) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
TOLMAR
Teva
Sandoz (Novartis)
SciAnda Pharma
Daewoong
Nanox
GP Pharm
Enteris BioPharma
Xbrane Biopharma
Camurus
Chong Kun Dang
Takeda
Segment by Type
Leucorin Acetate For Injection
Liulinruilin Acetate Injection
Segment by Application
Breast Cancer
Endometriosis
Uterine Fibrosis
Prostate Cancer
Infertility
Precocious Puberty
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enanton (Leucorin Acetate) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enanton (Leucorin Acetate) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Leuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer's disease.
The global Enanton (Leucorin Acetate) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Enanton (Leucorin Acetate) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enanton (Leucorin Acetate) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enanton (Leucorin Acetate) include Sanofi, TOLMAR, Teva, Sandoz (Novartis), SciAnda Pharma, Daewoong, Nanox, GP Pharm and Enteris BioPharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enanton (Leucorin Acetate), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enanton (Leucorin Acetate).
Report Scope
The Enanton (Leucorin Acetate) market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enanton (Leucorin Acetate) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enanton (Leucorin Acetate) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
TOLMAR
Teva
Sandoz (Novartis)
SciAnda Pharma
Daewoong
Nanox
GP Pharm
Enteris BioPharma
Xbrane Biopharma
Camurus
Chong Kun Dang
Takeda
Segment by Type
Leucorin Acetate For Injection
Liulinruilin Acetate Injection
Segment by Application
Breast Cancer
Endometriosis
Uterine Fibrosis
Prostate Cancer
Infertility
Precocious Puberty
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enanton (Leucorin Acetate) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enanton (Leucorin Acetate) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Enanton (Leucorin Acetate) Market Overview
1.1 Product Overview and Scope of Enanton (Leucorin Acetate)
1.2 Enanton (Leucorin Acetate) Segment by Type
1.2.1 Global Enanton (Leucorin Acetate) Market Value Comparison by Type (2024-2030)
1.2.2 Leucorin Acetate For Injection
1.2.3 Liulinruilin Acetate Injection
1.3 Enanton (Leucorin Acetate) Segment by Application
1.3.1 Global Enanton (Leucorin Acetate) Market Value by Application: (2024-2030)
1.3.2 Breast Cancer
1.3.3 Endometriosis
1.3.4 Uterine Fibrosis
1.3.5 Prostate Cancer
1.3.6 Infertility
1.3.7 Precocious Puberty
1.3.8 Other
1.4 Global Enanton (Leucorin Acetate) Market Size Estimates and Forecasts
1.4.1 Global Enanton (Leucorin Acetate) Revenue 2019-2030
1.4.2 Global Enanton (Leucorin Acetate) Sales 2019-2030
1.4.3 Global Enanton (Leucorin Acetate) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enanton (Leucorin Acetate) Market Competition by Manufacturers
2.1 Global Enanton (Leucorin Acetate) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enanton (Leucorin Acetate) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enanton (Leucorin Acetate) Average Price by Manufacturers (2019-2024)
2.4 Global Enanton (Leucorin Acetate) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enanton (Leucorin Acetate), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enanton (Leucorin Acetate), Product Type & Application
2.7 Enanton (Leucorin Acetate) Market Competitive Situation and Trends
2.7.1 Enanton (Leucorin Acetate) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enanton (Leucorin Acetate) Players Market Share by Revenue
2.7.3 Global Enanton (Leucorin Acetate) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enanton (Leucorin Acetate) Retrospective Market Scenario by Region
3.1 Global Enanton (Leucorin Acetate) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enanton (Leucorin Acetate) Global Enanton (Leucorin Acetate) Sales by Region: 2019-2030
3.2.1 Global Enanton (Leucorin Acetate) Sales by Region: 2019-2024
3.2.2 Global Enanton (Leucorin Acetate) Sales by Region: 2025-2030
3.3 Global Enanton (Leucorin Acetate) Global Enanton (Leucorin Acetate) Revenue by Region: 2019-2030
3.3.1 Global Enanton (Leucorin Acetate) Revenue by Region: 2019-2024
3.3.2 Global Enanton (Leucorin Acetate) Revenue by Region: 2025-2030
3.4 North America Enanton (Leucorin Acetate) Market Facts & Figures by Country
3.4.1 North America Enanton (Leucorin Acetate) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enanton (Leucorin Acetate) Sales by Country (2019-2030)
3.4.3 North America Enanton (Leucorin Acetate) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Enanton (Leucorin Acetate) Market Facts & Figures by Country
3.5.1 Europe Enanton (Leucorin Acetate) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enanton (Leucorin Acetate) Sales by Country (2019-2030)
3.5.3 Europe Enanton (Leucorin Acetate) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enanton (Leucorin Acetate) Market Facts & Figures by Country
3.6.1 Asia Pacific Enanton (Leucorin Acetate) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enanton (Leucorin Acetate) Sales by Country (2019-2030)
3.6.3 Asia Pacific Enanton (Leucorin Acetate) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Enanton (Leucorin Acetate) Market Facts & Figures by Country
3.7.1 Latin America Enanton (Leucorin Acetate) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enanton (Leucorin Acetate) Sales by Country (2019-2030)
3.7.3 Latin America Enanton (Leucorin Acetate) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enanton (Leucorin Acetate) Market Facts & Figures by Country
3.8.1 Middle East and Africa Enanton (Leucorin Acetate) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enanton (Leucorin Acetate) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enanton (Leucorin Acetate) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enanton (Leucorin Acetate) Sales by Type (2019-2030)
4.1.1 Global Enanton (Leucorin Acetate) Sales by Type (2019-2024)
4.1.2 Global Enanton (Leucorin Acetate) Sales by Type (2025-2030)
4.1.3 Global Enanton (Leucorin Acetate) Sales Market Share by Type (2019-2030)
4.2 Global Enanton (Leucorin Acetate) Revenue by Type (2019-2030)
4.2.1 Global Enanton (Leucorin Acetate) Revenue by Type (2019-2024)
4.2.2 Global Enanton (Leucorin Acetate) Revenue by Type (2025-2030)
4.2.3 Global Enanton (Leucorin Acetate) Revenue Market Share by Type (2019-2030)
4.3 Global Enanton (Leucorin Acetate) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enanton (Leucorin Acetate) Sales by Application (2019-2030)
5.1.1 Global Enanton (Leucorin Acetate) Sales by Application (2019-2024)
5.1.2 Global Enanton (Leucorin Acetate) Sales by Application (2025-2030)
5.1.3 Global Enanton (Leucorin Acetate) Sales Market Share by Application (2019-2030)
5.2 Global Enanton (Leucorin Acetate) Revenue by Application (2019-2030)
5.2.1 Global Enanton (Leucorin Acetate) Revenue by Application (2019-2024)
5.2.2 Global Enanton (Leucorin Acetate) Revenue by Application (2025-2030)
5.2.3 Global Enanton (Leucorin Acetate) Revenue Market Share by Application (2019-2030)
5.3 Global Enanton (Leucorin Acetate) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Enanton (Leucorin Acetate) Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 TOLMAR
6.2.1 TOLMAR Corporation Information
6.2.2 TOLMAR Description and Business Overview
6.2.3 TOLMAR Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 TOLMAR Enanton (Leucorin Acetate) Product Portfolio
6.2.5 TOLMAR Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Enanton (Leucorin Acetate) Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Sandoz (Novartis)
6.4.1 Sandoz (Novartis) Corporation Information
6.4.2 Sandoz (Novartis) Description and Business Overview
6.4.3 Sandoz (Novartis) Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz (Novartis) Enanton (Leucorin Acetate) Product Portfolio
6.4.5 Sandoz (Novartis) Recent Developments/Updates
6.5 SciAnda Pharma
6.5.1 SciAnda Pharma Corporation Information
6.5.2 SciAnda Pharma Description and Business Overview
6.5.3 SciAnda Pharma Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SciAnda Pharma Enanton (Leucorin Acetate) Product Portfolio
6.5.5 SciAnda Pharma Recent Developments/Updates
6.6 Daewoong
6.6.1 Daewoong Corporation Information
6.6.2 Daewoong Description and Business Overview
6.6.3 Daewoong Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Daewoong Enanton (Leucorin Acetate) Product Portfolio
6.6.5 Daewoong Recent Developments/Updates
6.7 Nanox
6.6.1 Nanox Corporation Information
6.6.2 Nanox Description and Business Overview
6.6.3 Nanox Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nanox Enanton (Leucorin Acetate) Product Portfolio
6.7.5 Nanox Recent Developments/Updates
6.8 GP Pharm
6.8.1 GP Pharm Corporation Information
6.8.2 GP Pharm Description and Business Overview
6.8.3 GP Pharm Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GP Pharm Enanton (Leucorin Acetate) Product Portfolio
6.8.5 GP Pharm Recent Developments/Updates
6.9 Enteris BioPharma
6.9.1 Enteris BioPharma Corporation Information
6.9.2 Enteris BioPharma Description and Business Overview
6.9.3 Enteris BioPharma Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Enteris BioPharma Enanton (Leucorin Acetate) Product Portfolio
6.9.5 Enteris BioPharma Recent Developments/Updates
6.10 Xbrane Biopharma
6.10.1 Xbrane Biopharma Corporation Information
6.10.2 Xbrane Biopharma Description and Business Overview
6.10.3 Xbrane Biopharma Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Xbrane Biopharma Enanton (Leucorin Acetate) Product Portfolio
6.10.5 Xbrane Biopharma Recent Developments/Updates
6.11 Camurus
6.11.1 Camurus Corporation Information
6.11.2 Camurus Enanton (Leucorin Acetate) Description and Business Overview
6.11.3 Camurus Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Camurus Enanton (Leucorin Acetate) Product Portfolio
6.11.5 Camurus Recent Developments/Updates
6.12 Chong Kun Dang
6.12.1 Chong Kun Dang Corporation Information
6.12.2 Chong Kun Dang Enanton (Leucorin Acetate) Description and Business Overview
6.12.3 Chong Kun Dang Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Chong Kun Dang Enanton (Leucorin Acetate) Product Portfolio
6.12.5 Chong Kun Dang Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Corporation Information
6.13.2 Takeda Enanton (Leucorin Acetate) Description and Business Overview
6.13.3 Takeda Enanton (Leucorin Acetate) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Takeda Enanton (Leucorin Acetate) Product Portfolio
6.13.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enanton (Leucorin Acetate) Industry Chain Analysis
7.2 Enanton (Leucorin Acetate) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enanton (Leucorin Acetate) Production Mode & Process
7.4 Enanton (Leucorin Acetate) Sales and Marketing
7.4.1 Enanton (Leucorin Acetate) Sales Channels
7.4.2 Enanton (Leucorin Acetate) Distributors
7.5 Enanton (Leucorin Acetate) Customers
8 Enanton (Leucorin Acetate) Market Dynamics
8.1 Enanton (Leucorin Acetate) Industry Trends
8.2 Enanton (Leucorin Acetate) Market Drivers
8.3 Enanton (Leucorin Acetate) Market Challenges
8.4 Enanton (Leucorin Acetate) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Enanton (Leucorin Acetate) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Enanton (Leucorin Acetate) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Enanton (Leucorin Acetate) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Enanton (Leucorin Acetate) Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Enanton (Leucorin Acetate) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Enanton (Leucorin Acetate) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Enanton (Leucorin Acetate) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Enanton (Leucorin Acetate) Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Enanton (Leucorin Acetate), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Enanton (Leucorin Acetate), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enanton (Leucorin Acetate), Product Type & Application
Table 12. Global Key Manufacturers of Enanton (Leucorin Acetate), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enanton (Leucorin Acetate) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enanton (Leucorin Acetate) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enanton (Leucorin Acetate) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Enanton (Leucorin Acetate) Sales by Region (2019-2024) & (KG)
Table 18. Global Enanton (Leucorin Acetate) Sales Market Share by Region (2019-2024)
Table 19. Global Enanton (Leucorin Acetate) Sales by Region (2025-2030) & (KG)
Table 20. Global Enanton (Leucorin Acetate) Sales Market Share by Region (2025-2030)
Table 21. Global Enanton (Leucorin Acetate) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Enanton (Leucorin Acetate) Revenue Market Share by Region (2019-2024)
Table 23. Global Enanton (Leucorin Acetate) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Enanton (Leucorin Acetate) Revenue Market Share by Region (2025-2030)
Table 25. North America Enanton (Leucorin Acetate) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Enanton (Leucorin Acetate) Sales by Country (2019-2024) & (KG)
Table 27. North America Enanton (Leucorin Acetate) Sales by Country (2025-2030) & (KG)
Table 28. North America Enanton (Leucorin Acetate) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Enanton (Leucorin Acetate) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Enanton (Leucorin Acetate) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Enanton (Leucorin Acetate) Sales by Country (2019-2024) & (KG)
Table 32. Europe Enanton (Leucorin Acetate) Sales by Country (2025-2030) & (KG)
Table 33. Europe Enanton (Leucorin Acetate) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Enanton (Leucorin Acetate) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Enanton (Leucorin Acetate) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Enanton (Leucorin Acetate) Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Enanton (Leucorin Acetate) Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Enanton (Leucorin Acetate) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Enanton (Leucorin Acetate) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Enanton (Leucorin Acetate) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Enanton (Leucorin Acetate) Sales by Country (2019-2024) & (KG)
Table 42. Latin America Enanton (Leucorin Acetate) Sales by Country (2025-2030) & (KG)
Table 43. Latin America Enanton (Leucorin Acetate) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Enanton (Leucorin Acetate) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Enanton (Leucorin Acetate) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Enanton (Leucorin Acetate) Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Enanton (Leucorin Acetate) Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Enanton (Leucorin Acetate) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Enanton (Leucorin Acetate) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Enanton (Leucorin Acetate) Sales (KG) by Type (2019-2024)
Table 51. Global Enanton (Leucorin Acetate) Sales (KG) by Type (2025-2030)
Table 52. Global Enanton (Leucorin Acetate) Sales Market Share by Type (2019-2024)
Table 53. Global Enanton (Leucorin Acetate) Sales Market Share by Type (2025-2030)
Table 54. Global Enanton (Leucorin Acetate) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Enanton (Leucorin Acetate) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Enanton (Leucorin Acetate) Revenue Market Share by Type (2019-2024)
Table 57. Global Enanton (Leucorin Acetate) Revenue Market Share by Type (2025-2030)
Table 58. Global Enanton (Leucorin Acetate) Price (US$/G) by Type (2019-2024)
Table 59. Global Enanton (Leucorin Acetate) Price (US$/G) by Type (2025-2030)
Table 60. Global Enanton (Leucorin Acetate) Sales (KG) by Application (2019-2024)
Table 61. Global Enanton (Leucorin Acetate) Sales (KG) by Application (2025-2030)
Table 62. Global Enanton (Leucorin Acetate) Sales Market Share by Application (2019-2024)
Table 63. Global Enanton (Leucorin Acetate) Sales Market Share by Application (2025-2030)
Table 64. Global Enanton (Leucorin Acetate) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Enanton (Leucorin Acetate) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Enanton (Leucorin Acetate) Revenue Market Share by Application (2019-2024)
Table 67. Global Enanton (Leucorin Acetate) Revenue Market Share by Application (2025-2030)
Table 68. Global Enanton (Leucorin Acetate) Price (US$/G) by Application (2019-2024)
Table 69. Global Enanton (Leucorin Acetate) Price (US$/G) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Sanofi Enanton (Leucorin Acetate) Product
Table 74. Sanofi Recent Developments/Updates
Table 75. TOLMAR Corporation Information
Table 76. TOLMAR Description and Business Overview
Table 77. TOLMAR Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. TOLMAR Enanton (Leucorin Acetate) Product
Table 79. TOLMAR Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Teva Enanton (Leucorin Acetate) Product
Table 84. Teva Recent Developments/Updates
Table 85. Sandoz (Novartis) Corporation Information
Table 86. Sandoz (Novartis) Description and Business Overview
Table 87. Sandoz (Novartis) Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Sandoz (Novartis) Enanton (Leucorin Acetate) Product
Table 89. Sandoz (Novartis) Recent Developments/Updates
Table 90. SciAnda Pharma Corporation Information
Table 91. SciAnda Pharma Description and Business Overview
Table 92. SciAnda Pharma Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. SciAnda Pharma Enanton (Leucorin Acetate) Product
Table 94. SciAnda Pharma Recent Developments/Updates
Table 95. Daewoong Corporation Information
Table 96. Daewoong Description and Business Overview
Table 97. Daewoong Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Daewoong Enanton (Leucorin Acetate) Product
Table 99. Daewoong Recent Developments/Updates
Table 100. Nanox Corporation Information
Table 101. Nanox Description and Business Overview
Table 102. Nanox Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Nanox Enanton (Leucorin Acetate) Product
Table 104. Nanox Recent Developments/Updates
Table 105. GP Pharm Corporation Information
Table 106. GP Pharm Description and Business Overview
Table 107. GP Pharm Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. GP Pharm Enanton (Leucorin Acetate) Product
Table 109. GP Pharm Recent Developments/Updates
Table 110. Enteris BioPharma Corporation Information
Table 111. Enteris BioPharma Description and Business Overview
Table 112. Enteris BioPharma Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Enteris BioPharma Enanton (Leucorin Acetate) Product
Table 114. Enteris BioPharma Recent Developments/Updates
Table 115. Xbrane Biopharma Corporation Information
Table 116. Xbrane Biopharma Description and Business Overview
Table 117. Xbrane Biopharma Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. Xbrane Biopharma Enanton (Leucorin Acetate) Product
Table 119. Xbrane Biopharma Recent Developments/Updates
Table 120. Camurus Corporation Information
Table 121. Camurus Description and Business Overview
Table 122. Camurus Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Camurus Enanton (Leucorin Acetate) Product
Table 124. Camurus Recent Developments/Updates
Table 125. Chong Kun Dang Corporation Information
Table 126. Chong Kun Dang Description and Business Overview
Table 127. Chong Kun Dang Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Chong Kun Dang Enanton (Leucorin Acetate) Product
Table 129. Chong Kun Dang Recent Developments/Updates
Table 130. Takeda Corporation Information
Table 131. Takeda Description and Business Overview
Table 132. Takeda Enanton (Leucorin Acetate) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. Takeda Enanton (Leucorin Acetate) Product
Table 134. Takeda Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Enanton (Leucorin Acetate) Distributors List
Table 138. Enanton (Leucorin Acetate) Customers List
Table 139. Enanton (Leucorin Acetate) Market Trends
Table 140. Enanton (Leucorin Acetate) Market Drivers
Table 141. Enanton (Leucorin Acetate) Market Challenges
Table 142. Enanton (Leucorin Acetate) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enanton (Leucorin Acetate)
Figure 2. Global Enanton (Leucorin Acetate) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Enanton (Leucorin Acetate) Market Share by Type in 2023 & 2030
Figure 4. Leucorin Acetate For Injection Product Picture
Figure 5. Liulinruilin Acetate Injection Product Picture
Figure 6. Global Enanton (Leucorin Acetate) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Enanton (Leucorin Acetate) Market Share by Application in 2023 & 2030
Figure 8. Breast Cancer
Figure 9. Endometriosis
Figure 10. Uterine Fibrosis
Figure 11. Prostate Cancer
Figure 12. Infertility
Figure 13. Precocious Puberty
Figure 14. Other
Figure 15. Global Enanton (Leucorin Acetate) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Enanton (Leucorin Acetate) Market Size (2019-2030) & (US$ Million)
Figure 17. Global Enanton (Leucorin Acetate) Sales (2019-2030) & (KG)
Figure 18. Global Enanton (Leucorin Acetate) Average Price (US$/G) & (2019-2030)
Figure 19. Enanton (Leucorin Acetate) Report Years Considered
Figure 20. Enanton (Leucorin Acetate) Sales Share by Manufacturers in 2023
Figure 21. Global Enanton (Leucorin Acetate) Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Enanton (Leucorin Acetate) Players: Market Share by Revenue in 2023
Figure 23. Enanton (Leucorin Acetate) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Enanton (Leucorin Acetate) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Enanton (Leucorin Acetate) Sales Market Share by Country (2019-2030)
Figure 26. North America Enanton (Leucorin Acetate) Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Enanton (Leucorin Acetate) Sales Market Share by Country (2019-2030)
Figure 30. Europe Enanton (Leucorin Acetate) Revenue Market Share by Country (2019-2030)
Figure 31. Germany Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Enanton (Leucorin Acetate) Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Enanton (Leucorin Acetate) Revenue Market Share by Region (2019-2030)
Figure 38. China Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Enanton (Leucorin Acetate) Sales Market Share by Country (2019-2030)
Figure 49. Latin America Enanton (Leucorin Acetate) Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Enanton (Leucorin Acetate) Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Enanton (Leucorin Acetate) Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Enanton (Leucorin Acetate) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Enanton (Leucorin Acetate) by Type (2019-2030)
Figure 59. Global Revenue Market Share of Enanton (Leucorin Acetate) by Type (2019-2030)
Figure 60. Global Enanton (Leucorin Acetate) Price (US$/G) by Type (2019-2030)
Figure 61. Global Sales Market Share of Enanton (Leucorin Acetate) by Application (2019-2030)
Figure 62. Global Revenue Market Share of Enanton (Leucorin Acetate) by Application (2019-2030)
Figure 63. Global Enanton (Leucorin Acetate) Price (US$/G) by Application (2019-2030)
Figure 64. Enanton (Leucorin Acetate) Value Chain
Figure 65. Enanton (Leucorin Acetate) Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
